Page 9 - Synairgen Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Synairgen plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Synairgen Plc Today - Breaking & Trending Today

Small cap movers:Synairgen PLC soars after encouraging COVID-related lab tests while the tide turns for SIMEC Atlantis Energy Ltd

A look at some of the week s big movers in the small cap world ....

United Kingdom , Hurricane Energy , Morgan Stanley , Spire Healthcare , Ministry Of Economy , South African , Wuhan Like Coronavirus , Naru Island , Rob Pitcher , Small Cap Movers , Proactive Wraps , Market Report , Synairgen Plc , Lon Sng , ஒன்றுபட்டது கிஂக்டம் , சூறாவளி ஆற்றல் , மோர்கன் ஸ்டான்லி , ஸ்பைர் சுகாதாரம் , அமைச்சகம் ஆஃப் பொருளாதாரம் , நரு தீவு , கொள்ளை பிட்சர் , ப்ரோவாக்டிவ் மறைப்புகள் ,

Synairgen PLC says Covid treatment has shown potent antiviral activity against two Covid variants

Synairgen says Covid treatment has shown potent antiviral activity against two Covid variants
In vitro” experiments were carried out to assess the drug’s potential efficacy against the Kent and South African mutations
Synairgen PLC (LON:SNG) said lab tests of its inhaled interferon beta, which is being developed to treat people with severe effects of Covid, has shown “potent antiviral activity” against two new variants of the SARS-CoV-2.
The lab tests of SNG001 also demonstrated the “broad-spectrum antiviral activity , which bodes well for its use across a number of respiratory viruses.
The “in vitro” experiments were carried out to assess the drug’s potential efficacy against the Kent and South African Covid mutations. ....

Stephen Holgate , South African Covid , Sir Stephen Holgate , Small Caps , Harma Biotech , Synairgen Plc , Lon Sng , ஸ்டீபன் ஹோல்கேட் , ஐயா ஸ்டீபன் ஹோல்கேட் , சிறிய தொப்பிகள் ,

Synairgen PLC says COVID treatment has shown potent antiviral activity against two variants

Synairgen says COVID treatment has shown potent antiviral activity against two variants
In vitro” experiments were carried out to assess the drug’s potential efficacy against the Kent and South African mutations
Synairgen PLC (LON:SNG) said lab tests of its inhaled interferon beta, which is being developed to treat people with severe effects of COVID, has shown “potent antiviral activity” against two new variants of the SARS-CoV-2.
The lab tests of SNG001 also demonstrated the “broad-spectrum antiviral activity , which bodes well for its use across a number of respiratory viruses.
The “in vitro” experiments were carried out to assess the drug’s potential efficacy against the Kent and South African COVID mutations. ....

Stephen Holgate , South African , Wuhan Like Coronavirus , Sir Stephen Holgate , Small Caps , Harma Biotech , Synairgen Plc , Lon Sng , ஸ்டீபன் ஹோல்கேட் , ஐயா ஸ்டீபன் ஹோல்கேட் , சிறிய தொப்பிகள் ,

Synairgen PLC hails exceptional progress over 2020 towards treatment for COVID-19

Synairgen hails exceptional progress over 2020 towards treatment for COVID-19
The company said a Phase III trial of its SNG001 candidate was initiated last year with the results expected in the second half of 2021
Synairgen PLC’s (LON:SNG) chief executive has hailed “exceptional progress” for the group over 2020 as it continued to develop its treatment for coronavirus (COVID-19) infections.
In its results for the year to December 31, 2020, the company reported positive results and data from a number of trials of its interferon beta-1a (SNG001) treatment candidate, with the results of a Phase II trial in 101 hospitalised COVID-19 patients reported last July. ....

Richard Marsden , Small Caps , Harma Biotech , Synairgen Plc , Lon Sng , ரிச்சர்ட் மார்ஸ்டன் , சிறிய தொப்பிகள் ,